Cargando…
Wnt signaling in triple-negative breast cancer
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregula...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520491/ https://www.ncbi.nlm.nih.gov/pubmed/28368389 http://dx.doi.org/10.1038/oncsis.2017.14 |
_version_ | 1783251822520041472 |
---|---|
author | Pohl, SÖ-G Brook, N Agostino, M Arfuso, F Kumar, A P Dharmarajan, A |
author_facet | Pohl, SÖ-G Brook, N Agostino, M Arfuso, F Kumar, A P Dharmarajan, A |
author_sort | Pohl, SÖ-G |
collection | PubMed |
description | Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease. |
format | Online Article Text |
id | pubmed-5520491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55204912017-07-28 Wnt signaling in triple-negative breast cancer Pohl, SÖ-G Brook, N Agostino, M Arfuso, F Kumar, A P Dharmarajan, A Oncogenesis Review Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease. Nature Publishing Group 2017-04 2017-04-03 /pmc/articles/PMC5520491/ /pubmed/28368389 http://dx.doi.org/10.1038/oncsis.2017.14 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ Oncogenesis is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Review Pohl, SÖ-G Brook, N Agostino, M Arfuso, F Kumar, A P Dharmarajan, A Wnt signaling in triple-negative breast cancer |
title | Wnt signaling in triple-negative breast cancer |
title_full | Wnt signaling in triple-negative breast cancer |
title_fullStr | Wnt signaling in triple-negative breast cancer |
title_full_unstemmed | Wnt signaling in triple-negative breast cancer |
title_short | Wnt signaling in triple-negative breast cancer |
title_sort | wnt signaling in triple-negative breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520491/ https://www.ncbi.nlm.nih.gov/pubmed/28368389 http://dx.doi.org/10.1038/oncsis.2017.14 |
work_keys_str_mv | AT pohlsog wntsignalingintriplenegativebreastcancer AT brookn wntsignalingintriplenegativebreastcancer AT agostinom wntsignalingintriplenegativebreastcancer AT arfusof wntsignalingintriplenegativebreastcancer AT kumarap wntsignalingintriplenegativebreastcancer AT dharmarajana wntsignalingintriplenegativebreastcancer |